While we have reported on the robust immunogenicity of monovalent bicistronic sa-mRNA-HA-NA vaccines previously27, it remains an open question whether the platform is capable of inducing immune responses to the eight antigenic targets necessary for a quadrivalent seasonal influenza vaccine encoding both HA and NA. The gene discussed is XK; the disease is influenza.